Patient P-01333
Synthetic patientNBL-101 · Day 108 · 25–34 · M · baseline S06Steering view · 3DOpen companion preview
Therapy response
Declining
Tolerance
Favorable
GI state
Improving
Inflammatory state
Favorable
Nutritional resilience
Favorable
Discontinuation risk
16%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 NBL-101 started — Baseline state S06
- Day 10 Trajectory diverged from prediction — Observed response fell below the model's expected path.
What changed?
Trajectory began diverging from predicted response on Day 10.
Primary contributors, last 14 days
- Treatment adherence-5
- GI instability-4
What helped?
No interventions yet.
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
GI burden
Companion24.2/100
stable · -0.4 vs previous 14 d
Toxicity
Blood17.6/100
improving · -5.9 vs previous 14 d
Sleep quality
Wearable37.2/100
improving · +3.9 vs previous 14 d
Energy level
Daily log5.3/10
improving · +0.2 vs previous 14 d
Stress level
Daily log3.4/10
improving · -0.2 vs previous 14 d
Steps
Wearable6,302
stable · -230 vs previous 14 d
Adherence
Companion92.4 %
stable · +0.9 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →Heading towards failing · 65 from the failing basin, 31 from restoration.
Would help
- No untried action with strong evidence. Compose one from primitives.
Would not help
- Keep histamine lowGI +6.6 next day on high-intake days · n 14
- Keep fat lowGI +5.4 next day on high-intake days · n 19
- Keep simple carbs lowGI +2.8 next day on high-intake days · n 18
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Histamine load+6.6detractor · 95%
- Dietary fat load+5.4detractor · 95%
- Simple carbohydrates+2.8detractor · 66%
- Insoluble fibre-0.7no signal · 16%
- Alcohol+0.6no signal · 15%
- Spicy / capsaicin-0.3no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Mucosal barrier integrity ↓70
- DNAFUT2 non-secretor lowers mucosal fucosylation
- MicrobiomeAkkermansia low → thinner mucus layer
- WearableSleep 5.9 h, below personal baseline
- Butyrate / short-chain fatty acid production ↓35
- MicrobiomeButyrate capacity 41/100
- Drug metabolism and exposure ↑35
- DNADPYD *2A → slower clearance
- Autonomic recovery ↓20
- WearableShort sleep window
DNA
Fictional pharmacogenomic panel
- FUT2 rs601338 AA (non-secretor)Reduced mucosal fucosylation
- DPYD *2A heterozygousSlower drug clearance
- CYP2D6 Intermediate metabolizerExpected exposure
Microbiome
Shannon diversity 1.9 · butyrate capacity 41/100
- Akkermansia muciniphilaLow
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisNormal
- Bifidobacterium longumLow
- EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 63 ms
- Sleep
- 6.3 h
- Steps
- 6,322
- Resting HR
- 58 bpm
Daily log: GI score 24, nutritional resilience 62, adherence 92.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
- Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Protect a 7.5-hour sleep window; screens off 30 minutes before
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the scheduled dose as agreed with your care team
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.
| Patient | Similarity | Baseline | Intervention | Outcome | Response today |
|---|---|---|---|---|---|
| P-01861 | 54% | S12 | HY-01 | improved | 47 |
| P-01555 | 50% | S06 | GI-04 | improved | 56 |
| P-01752 | 46% | S20 | DT-01 | improved | 50 |
| P-01374 | 45% | S08 | HY-01 | improved | 49 |
| P-01342 | 42% | S11 | DT-01 | improved | 48 |
| P-01385 | 41% | S06 | HY-01 | improved | 50 |
| P-01618 | 41% | S10 | GI-04 | improved | 39 |
| P-01571 | 40% | S13 | SC-12 | improved | 57 |
| P-01455 | 39% | S01 | GI-04 | improved | 61 |
| P-01346 | 38% | S12 | DT-01 | improved | 52 |
| P-01724 | 38% | S10 | DT-01 | improved | 63 |
| P-01593 | 37% | S10 | HY-01 | improved | 56 |